Fintel reports that on March 25, 2025, Maxim Group downgraded their outlook for CNS Pharmaceuticals (NasdaqCM:CNSP) from Buy ...

Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for Moleculin Biotech (NasdaqCM:MBRX) from Hold to ...

Maxim Group reissued their hold rating on shares of CNS Pharmaceuticals (NASDAQ:CNSP – Free Report) in a report issued on ...

Maxim Group analyst Matthew Galinko maintained a Buy rating on SEALSQ Corp (LAES – Research Report) yesterday and set a price target of $6.00.

Wang & Lee Group entered into a securities purchase agreement with certain institutional investors for the purchase and sale ...

Maxim Group analyst Naz Rahman reiterated a Buy rating on Palisade Bio (PALI – Research Report) yesterday. The company’s shares opened today at ...

Maxim Group reissued their hold rating on shares of Solaris Resources (NYSEAMERICAN:SLSR – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. Solaris Resources Stock ...

Fintel reports that on March 24, 2025, Maxim Group upgraded their outlook for Nexalin Technology (NasdaqCM:NXL) from Hold to Buy. As of December 3, 2024, the average one-year price target for ...

Wang & Lee Group shares are trading lower by 84% during Monday's session. The company announced pricing of a securities purchase agreement with institutional investors.

Fintel reports that on March 21, 2025, Maxim Group initiated coverage of Anixa Biosciences (NasdaqCM:ANIX) with a Buy recommendation. As of March 19, 2025, the average one-year price target for ...

Maxim Group LLC is acting as sole placement agent in connection with the offering. The securities above are being offered pursuant to a registration statement on Form F-1, as amended, (File No ...

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals Maxim Group ...